Infección por SARS-CoV2, epidemiología, manifestaciones clínicas, inmunología: tratando de entender la enfermedad
Palabras clave:
COVID-19, Comorbilidades, Manifestaciones clínicas, Neumonía viral, Tormenta de citoquinasResumen
-
Referencias
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19 [published online ahead of print, 2020 Mar 28]. Int J AntimicrobAgents. 2020;105955. doi:10.1016/j.ijantimicag.2020.105955
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
Xiao C, Li X, Liu S, Sang Y, Gao SJ, Gao F. HIV-1 did not contribute to the 2019-nCoV genome. Emerg Microbes Infect. 2020;9(1):378–381. Published 2020 Feb 14. doi:10.1080/22221751.2020.1727299
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China [published correction appears in Nature. 2020 Apr;580(7803): E7]. Nature. 2020;579(7798):265–269. doi:10.1038/s41586-020-2008-3
Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. Marzo 7, 2020;395(10226):809-815.
Chen L, Li Q, Zheng D, Jiang H, Wi Y, Zou L, et al. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China [published online ahead of print, 2020 Apr 17]. N Engl J Med.2020;10.1056/NEJMc2009226. doi:10.1056/NEJMc2009226
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199–1207.doi:10.1056/NEJMoa2001316
Backer JA, Klinkenberg D, Wallinga J. Incubation Period of 2019 Novel Coronavirus (2019-nCoV) Infections among Travellers from Wuhan, China, 20-28 January 2020. Euro Surveill.2020;25(5):2000062. doi:10.2807/1560-7917.ES.2020.25.5.2000062
Zhang S, Diao MY, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. April 2020;93:201-204.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis [published online ahead of print, 2020 Mar 13]. Travel Med Infect Dis. 2020;101623. doi:10.1016/j.tmaid.2020.101623
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19 [published online ahead of print, 2020 Feb 21]. JAMA. 2020;323(14):1406–1407. doi:10.1001/jama.2020.2565
Zhonghua L, Xing B, Xue Z. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China]. 2020 Feb 17;41(2):145-151. PubMed PMID: 32064853
Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020;8(3):e13. doi:10.1016/S2213-2600(20)30066-7
JasperFuk-Woo C, Shuofeng Y, Kin-Hang K, Kai-Wang To K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514–23. PublishedOnline. January 24, 2020. https://doi.org/10.1016/.S0140-6736(20)30154-9
Mallapaty S. What the cruise-ship outbreaks reveal about COVID-19. Nature. 2020;580(7801):18.doi:10.1038/d41586-020-00885-w
Sutton D, Fuchs K, D’Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery [published online ahead of print, 2020 Apr 13]. N Engl J Med. 2020;10.1056/NEJMc2009316. doi:10.1056/NEJMc2009316
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. Published 2020 Mar 13. doi:10.1186/s40779-020-00240-0
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;e201585. doi:10.1001/jama.2020.1585
Lai CC, Liu YH, Wang CY, Hsueh SC, Yen MY, Ko WC, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths [published online ahead of print, 2020 Mar 4]. J Microbiol Immunol Infect. 2020;. doi:10.1016/j.jmii.2020.02.012
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929–936. doi:10.1056/NEJMoa2001191
Moein ST, Hashemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19 [published online ahead of print, 2020 Apr 17]. Int Forum Allergy Rhinol. 2020;10.1002/alr.22587. doi:10.1002/alr.22587
Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, et al. Features of anosmia in COVID-19 [published online ahead of print, 2020 Apr 16]. Med Mal Infect.2020;S0399-077X(20)30110-4. doi:10.1016/j.medmal.2020.04.006
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi:10.1016/j.jaut.2020.102433
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924
Alhazzani W, Moller MH, Arabi YM, Loeb M, Ng Gong M, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of criticallyill adults with Coronavirus Disease 2019 (COVID-19) [published online ahead of print, 2020 Mar 28]. Intensive Care Med. 2020;1–34.doi:10.1007/s00134-020-06022-5
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published online ahead of print, 2020 Mar 3] [published correction appears in Intensive Care Med. 2020 Apr 6;:]. Intensive Care Med. 2020;1–3. doi:10.1007/s00134-020-05991-x
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.doi:10.1111/jth.14768
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis [published online ahead of print, 2020 Mar 13]. ClinChim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
Amgalan A, Othman M. Exploring posible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions [published online ahead of print, 2020 Apr 11]. J ThrombHaemost.2020;10.1111/jth.14832. doi:10.1111/jth.14832
Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools [published online ahead of print, 2020 Mar 3]. Virol Sin. 2020;10.1007/s12250-020-00207-4. doi:10.1007/s12250-020-00207-4
Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematicreview of currentevidence. Ecancermedicalscience. 2020;14:1022. Published 2020 Mar 27. doi:10.3332/ecancer.2020.1022
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; (published online March 3.) DOI:10.1007/s00134-020-050991-x
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506
WHO Director-General’s opening remarks at the media briefing on COVID-19 - 3 March 2020 – World Health Organization, March 3, 2020.
Amy Harmon. Why We Don’t Know the True Death Rate for Covid-19. Ny Times. Published April 17, 2020. https://www.nytimes.com/2020/04/17/us/coronavirus-death-rate.html
